The impact of COVID-19 on the cancer research ecosystem is severe and relief is needed to ensure that labs and researchers can restart their operations once it is safe to do so. Federal assistance is essential to re-open labs and re-start clinical trials, so we do not lose any of the progress we have made in the fight against cancer. Congress can help create tomorrow’s cures and protect many more Americans from cancer, starting with its response to the COVID-19 pandemic.

COVID 19 and cancer research